SCOPE open access article published in Drug Safety
The Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action was aimed to help medicine regulators operate pharmacovigilance systems to the EU legislative requirements. Regulators have worked together to improve the skills and capability in the pharmacovigilance network to help safeguard public health in both national territories and the EU as a whole.
SCOPE open access article published in Drug Safety
Lead: Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Work package 1 delivers the coordination and project management functions for SCOPE
Lead: Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
This work package aims to effectively disseminate information about SCOPE and its deliverables
Lead: National Authority of Medicines and Health Products, I.P. (INFARMED), Portugal
This work package focusses on the evaluation of SCOPE to verify that the project is delivers what was planned to achieve the objectives
Lead: Agency for Medicinal Products and Medical Devices (HALMED), Croatia
This work package focuses on national adverse drug reaction reporting schemes, including patient reporting and efforts to improve awareness of national systems
Lead: Medicines Evaluation Board (MEB), Netherlands
This work package examines signal management at the level of the National Competent Agencies
Lead: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Spain
This work package focusses on risk communications about medicines, including communications tools and channels and their effectiveness
Lead: National Institute of Pharmacy and Nutrition (OGYÉI), Hungary
This work package aims to support quality standards in pharmacovigilance systems
Lead: Agenzia Italiana Del Farmaco (AIFA), Italy
The final work package examines aspects of pharmacovigilance assessment including assessor competency